Bain Capital in its $250 million minority growth investment in Sikich LLC, a global technology-enabled professional services company.
Blue Owl Finance LLC in its:
- Rule 144A/Regulation S offering of $750 million in aggregate principal amount of 6.25% senior notes due 2034.
- Rule 144A/Regulation S add-on offering of $250 million in aggregate principal amount of 6.25% senior notes due 2034.
Ares Management Corporation (NYSE: ARES) in its:
- $357 million underwritten public offering of Class A common stock.
- $500 million offering of 6.375% senior notes.
- $100 million investment in Vinci Partners (NASDAQ: VINP), an alternative investment platform.
InflaRx, a clinical-stage biopharmaceutical company, in:
- its $46 million underwritten public offering of ordinary shares following FDA emergency use authorization for its drug Gohibic (vilobelimab) for the treatment of critically ill, hospitalized COVID-19 patients.
- the amendment of its co-development agreement with Staidson BioPharmaceuticals to support Staidson in its regulatory approval efforts for its proprietary drug candidate in China and concurrent $2.5 million PIPE investment from Staidson.
Clearlake Capital Group in a $400 million senior notes offering to finance its acquisition of Intertape Polymer Group, a manufacturer of paper and film based pressure-sensitive and water-activated tapes, stretch and shrink films, protective packaging, woven and non-woven products and packaging machinery for industrial and retail use.
